SORINA CARABETH: Open Payments
NPI 1912039496 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 74 payments from 9 companies in 2025. Trend: 2023 $2,210 · 2024 $1,738 · 2025 $1,891
Food & beverage: $1,891
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $563 |
| ABBVIE INC. | 22 | $359 |
| Alkermes, Inc. | 5 | $236 |
| Bausch Health US, LLC | 9 | $188 |
| Axsome Therapeutics, Inc. | 6 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $166 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Almatica Pharma LLC | 3 | $62 |
| Tris Pharma Inc | 2 | $45 |
Products named: CAPLYTA, VRAYLAR, Auvelity, TRINTELLIX, APLENZIN, LYBALVI, ARISTADA, FANAPT.
Industry payments across CA — which companies pay providers there.
